LO FRANCIS sold ADPT

October 1, 2026 · Form 4 insider transaction

LO FRANCIS sold 8,094 shares of Adaptive Biotechnologies Corporation at $27.52 per share, a transaction worth $222.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Disposed (sell-side)
Shares
8,094
Price
$27.52
Total value
$222.7K
InsiderLO FRANCIS
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 1, 2026
Filing dateOctober 5, 2026
Shares owned after239,565
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025.; The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.22 to $28.22, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.

View the original Form 4 on SEC EDGAR
LO FRANCIS sold ADPT: October 1, 2026 | Insider Trading Screener